No Antipsychotic Drugs for Children
Antipsychotic drugs are the most potent brain altering chemicals; 90% of the
antipsychotics prescribed to children were: clozapine, risperidone, olanzapine,
and quetiapine. None of these drugs are approved for treating adolescents or
children.
There has been a sharp rise over the last decade in the prescription of
psychiatric drugs for children, including antipsychotics, stimulants like
Ritalin and antidepressants. The explosion in the use of drugs can be traced in
part to the growing number of children and adolescents whose problems are given
psychiatric labels once reserved for adults. Researchers, who analyzed data from
a national survey of doctors' office visits, found that antipsychotic
medications were prescribed to 1,438 per 100,000 children and adolescents in
2002, up from 275 per 100,000 in the two-year period from 1993 to 1995.
Pathak et al and colleagues found increases in the number of children younger
than 18 years in Virginia, USA newly treated with an antipsychotic drug; the
rate doubled between 2001 and 2005. There sample sample included 11,700
children. They also found that among new users, 41.3% had no diagnosis for which
treatment was supported by a published study. The highest level of
non–evidence-based use was with aripiprazole at 77.1%. (Pam Harrison. Medscape
Internal Medicine News. Unsupported Antipsychotic Use in Children Widespread.
Accessed online Feb 2010. Also see Psychiatr Serv. February 2010.)
First-time, antipsychotic use in children and adolescents is associated with
rapid and significant weight gain as well as hyperlipidemia, and insulin
resistance. A study of 272 pediatric patients showed that after a median of 10.8
weeks of treatment with antipsychotic medications, subjects gained an average of
18.7 pounds with olanzapine, 13.4 pounds with quetiapine, 11.7 pounds with
risperidone, and 9.7 pounds with aripiprazole. A total of 10% to 36% of study
participants transitioned to overweight or obese status within 11 weeks. (JAMA.
2009;302:1765–1773)
 In the USA, Harris stated: “As states begin to require that drug
companies disclose their payments to doctors for lectures and other services, a
pattern has emerged: psychiatrists earn more money from drug makers than doctors
in any other specialty. How this money may be influencing psychiatrists and
other doctors has become one of the most contentious issues in health care. For
instance, the more psychiatrists have earned from drug makers, the more they
have prescribed a new class of powerful medicines known as atypical
antipsychotics to children, for whom the drugs are especially risky and mostly
unapproved. Drug makers generally spend twice as much to market drugs as they do
to research them. ” (New York Times June 2007)
Harris pointed to yet another warning from a panel of federal drug experts
convened by the FDA in the US (2008) that antipsychotic medicines are being used
far too often in children with substantial risks. More than 389,000 children and
teenagers were treated in 2007 with Risperdal, one of five popular medicines
known as atypical antipsychotics; 240,000 were 12 or younger. The drug was often
prescribed to treat attention deficit disorders, an indication not approved
Involving risks which are “too profound to justify its use in treating such
disorders." The same concerns concerns applied to the other drugs in its class,
including Zyprexa, Seroquel, Abilify and Geodon.
The findings on the rising are likely to inflame a continuing debate about
the risks of using psychiatric medication in children. In recent years,
antidepressants have been linked to an increase in suicidal thinking or behavior
in some minors, and reports have suggested that stimulant drugs like Ritalin may
exacerbate underlying heart problems.
Antipsychotic drugs also carry risks: rapid weight gain and blood lipid
changes that increase the risk of diabetes. None of the most commonly prescribed
antipsychotics is approved for use in children, only a handful of small studies
have been done in children and adolescents.
(Reuters Health Information & Carey B. NYT June 6 2006. Reference Arch
Gen Psychiatry 2006;63:679-685 Gardiner Harris. Use of Antipsychotics in
Children Is Criticized. NYT November 19, 2008.)
- You are viewing the Brain Drugs at Alpha Online.
Understanding the human brain is essential to become a well-informed, modern
citizen. Stephen Gislason MD, the author of
the Human Brain, is a physician-writer who is good at making complex subjects more
understandable. This is a book with important ideas, so be prepared to read
and then keep the book as reference.
- Alpha Online is a Division of Environmed Research, founded in 1984 at
Vancouver, BC, Canada. Online Since 1995.
Alpha Nutrition is a trademark
and a division of Environmed Research Inc.
-
Download The Human Brain as an eBook
All Alpha Education and Persona Digital books, eBooks and Starter packs are ordered online.
Prices are listed in Canadian Dollars.
US $ cost is lower
depending on the daily dollar exchange rate. Physical shipments by the Post
Office are available to all destinations in the USA and Canada.
We are located in Sechelt, close to Vancouver, British Columbia, Canada. eMail:alphaonline@nutramed.com
Brain Rescue Starter Pack
This starter pack includes the Alpha Nutrition Program, the Human Brain in Health and Disease
and one 500 Gram jar of Alpha DMX. There are a host of clues that link the food supply to mysterious and threatening neurological
diseases. We suggest that a prudent person suffering early brain-dysfunction
symptoms would be wise to pursue vigorous, thorough diet revision at the
earliest opportunity. Because some brain dysfunction compromises judgment
learning and motivation, family members, friends and professional advisor often
have to initiate diet revision and provide the right direction and support.
Order Brain Rescue Starter Pack
Order Persona Digital Books
Click the Add to Cart buttons
on the left to begin your order for printed books from Alpha Online (mail delivery to US and
Canada).
Download eBooks Click the Download button to order
eBooks (PDF file) for download. Click book title (center column) to read topics
from each book.
Further reading: Neuroscience Notes, Intelligence and
Learning, Language & Thinking
Persona Digital Books is
the publisher of The Human Brain, Neuroscience Notes, Intelligence & Learning
and related books.
|
